Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Sleep Therapy System in Adults With Obstructive Sleep Apnea

NCT03559322 is registered in ClinicalTrials.gov with Somnics, Inc. as lead sponsor.

NCT NCT03559322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Sleep Therapy System in Adults With Obstructive Sleep Apnea
Lead sponsor
Somnics, Inc.
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2019
Completion date
December 30, 2021
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea of adult